FCVA Stock News 4.36 05/13/2014 14:38:09 First Capital Bancorp

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
First Capital Bancorp Inc. [Va] (FCVA) 4.36 $FCVA

First Capital Bancorp, Inc. Issues Correction to First Quarter of 2014 Press Release
GlobeNewswire - Thu May 08, 8:31AM CDT
First Capital Bancorp, Inc. (the "Company" (Nasdaq:FCVA) parent company to First Capital Bank (the "Bank" reported today a correction to its first quarter 2014 earnings announcement released on April 29, 2014.

First Capital Bancorp, Inc. Reports Net Income of $977 Thousand for the First Quarter of 2014, Net Income of $0.06 Per Diluted Share Outstanding, and Annualized Loan Growth of 12.81%
GlobeNewswire - Tue Apr 29, 7:08AM CDT
First Capital Bancorp, Inc. (the "Company" (Nasdaq:FCVA) parent company to First Capital Bank (the "Bank" reported today its financial results for the first quarter of 2014. For the three months ended March 31, 2014, the Company had net income of $977 thousand and net income available to common shareholders of $953 thousand, or $0.06 per diluted share, compared to net income of $795 thousand and net income available to common shareholders of $709 thousand, or $0.05 per diluted share, for the same period in 2013. This represents a $286 thousand or 25.24% increase in net income in the first quarter of 2014 compared to the first quarter of 2013, and a $244 thousand or 34.41% quarter to quarter increase in net income available to common shareholders.

First Capital Bancorp, Inc. Reports Net Income of $1.0 Million for the Fourth Quarter 2013, Full Year 2013 Net Income of $3.9 Million
GlobeNewswire - Wed Jan 29, 12:18PM CST
First Capital Bancorp, Inc. (the "Company" (Nasdaq:FCVA) parent company to First Capital Bank (the "Bank" reported today its financial results for the fourth quarter of 2013. For the three months ended December 31, 2013, the Company had net income of $1.0 million and net income available to common shareholders of $916 thousand, or $0.06 per diluted share, compared to net income of $641 thousand and net income available to common shareholders of $555 thousand, or $0.04 per diluted share, for the same period in 2012. This represents a $361 thousand or 56.32% increase in net income in the fourth quarter of 2013 compared to the fourth quarter of 2012 and a $360 thousand or 64.75% increase in net income available to common shareholders.

Sobi to take direct responsibility for Orfadin in the US, Canada and Latin America
Thomson Reuters ONE - Fri Dec 20, 5:03AM CST
Swedish Orphan Biovitrum AB (publ) (Sobi) announced today that the company has decided to take direct responsibility for Orfadin® in the US, Canada, and Latin America by terminating the current distributorship agreement with their partner Rare Disease Therapeutics, Inc (RDT). Financial details were not disclosed.

Nasdaq stocks posting largest volume increases
AP - Thu Dec 19, 5:03PM CST
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Webull Faces Class Action: Key Details for Investors

Updated Category News Views 306

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading
Fluence Energy Faces Leadership Departures Amid Legal Woes

Updated Category News Views 288

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 392

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 343

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading
PASCAL's Holiday Gift Edit: Timeless Watches Shine

Updated Category News Views 451

Fresh Sparkle for the Holidays Well, here we are again, staring down the barrel of another holiday season. And what do you know, PASCAL is out with its 2026 Holiday Gift Edit, like clockwork. This is the kind of stuff they’re good at—capturing a moment, slapping some color on it, and calling it a game-changer. Launching on November 14, this edit nods to their Timeless...

Continue Reading
BETR's Slide: Investors Face Big Losses, Leadership Shift

Updated Category News Views 216

BETR Investors Left in the Lurch It's a real trainwreck, folks. Better Home & Finance Holding Company, trading under NASDAQ:BETR, is in the spotlight for all the wrong reasons. The company expanded the class period for its investor lawsuit to include even more dates between March and August 2026, reflecting a torturous ride for shareholders. Their stock cratered by a...

Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 295

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
Layne's Chicken Fingers Expands with Brownsville Opening

Updated Category News Views 289

Fried Delights Rise in Brownsville Never thought I'd see the day when chicken fingers felt like the main character in an epic expansion saga, but here we are. Ricki Oberoi, a veteran in the fast-food game, is pushing onward with Layne's Chicken Fingers in Brownsville, Texas. I tell you, some folks are as keen on expanding their palates as they are their portfolios....

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 487

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 152

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
d -->

Top 5 Most Recently Viewed Articles

Addressing the Housing Crisis: Federal Funding Efforts

Updated Category News Views 313

Tackling Canada's Housing Crisis Canada is actively working to combat its housing crisis, with significant measures aimed at helping those who are homeless. While there’s a sense of hope in the air, the presence of encampments underscores the immediate need for long-lasting solutions. The federal government is stepping up its efforts, showing a dedicated resolve to...

Continue Reading
Rigetti Computing Readies for Third Quarter Results Announcement

Updated Category News Views 65

Rigetti Computing Announces Third Quarter Financial Results Rigetti Computing, Inc. (Nasdaq: RGTI), recognized as a leader in hybrid quantum-classical computing, has exciting news regarding its financial performance. The company is set to release its financial results for the third quarter of 2024 on a specified date, marking an important moment for stakeholders and...

Continue Reading
Novartis Reports Outstanding Q3 Performance and 2025 Outlook

Updated Category News Views 545

Solid Q3 Performance by Novartis In a significant announcement, Novartis reported an impressive growth in net sales and core operating income for the third quarter. During this period, the company's net sales reached USD 13.9 billion, reflecting a growth of 7% on a constant currency basis and an 8% increase in USD terms. Core operating income showed a similar trajectory,...

Continue Reading
Forestar Group Inc. Set to Announce First Quarter Earnings Soon

Updated Category News Views 134

Forestar Group Inc. to Announce First Quarter Earnings Forestar Group Inc. (NYSE: FOR) is preparing to share key financial results for its first quarter, marking the end of December 2024. This eagerly awaited announcement will take place shortly before the markets open on the designated day. Shareholders and interested parties will have the opportunity to hear about the...

Continue Reading
ImCheck Therapeutics Secures EMA Orphan Drug Designation

Updated Category News Views 196

ImCheck Therapeutics Secures EMA Orphan Drug Designation ImCheck Therapeutics has exciting news as it recently announced that the European Medicines Agency (EMA) has granted Orphan Drug Designation (ODD) to ICT01, its flagship treatment aimed at addressing acute myeloid leukemia (AML). This development, coming shortly after a similar designation from the U.S. FDA,...

Continue Reading